Status:
ENROLLING_BY_INVITATION
Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells
Lead Sponsor:
Scripps Translational Science Institute
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. W...
Eligibility Criteria
Inclusion
- Cases:
- Previously enrolled in the CAD module of the Genebank at Scripps Clinic Registry
- Eligible to have their blood drawn
- Be reliable, cooperative and willing to comply with all protocol-specified procedures
- Able to understand and grant informed consent
- Controls:
- Previously enrolled in the Healthy Elderly Active Longevity (HEAL) Cohort
- Eligible to have their blood drawn
- Be reliable, cooperative and willing to comply with all protocol-specified procedures
- Able to understand and grant informed consent
Exclusion
- Unwilling or unable to grant informed consent.
- Have a significant medical condition that in the Investigator's opinion may interfere with subject's study participation.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01517425
Start Date
November 1 2012
End Date
July 1 2030
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Translational Science Institute
La Jolla, California, United States, 92037